Predictive factors of the long‐term outcome in reflux esophagitis in a low‐prevalence gastroesophageal reflux disease region

References

• Locke GR III, Talley NJ, Fett SR, Zinsmeister AR, Melton LJ III. Prevalence and clinical spectrum of gastroesophageal reflux: a population based study in Olmsted Country, Minnesota. Gastroenterology 1997;112:1448–56.
   Google Scholar
• Kuster E, Ros E, Toledo-Pimentel V, Pujol A, Bordas JM, Grande L, et al. Predictive factors of the long term outcome in gastro-oesophageal reflux disease: six years follow up of 107 patients. Gut 1994;35: 8–14.
   Google Scholar
• Isolauri J, Luostarinen M, Isolauri E, Reinikainen P, Viljakka M, Keyrilainen O. Natural course of gastroesophageal reflux disease: 17–22 year follow-up of 60 patients. Am J Gastroenterol 1997;92:37–41.
   PubMed Web of Science ®Google Scholar
• Pilotto A, Francesci M, Leandro G, Novello R, DiMario F, Valerio G. Audit of reflux oesophagitis at 4 years. Ital J Gastroenterol Hepatol 1998;30:355–60.
   PubMedGoogle Scholar
• Ollyo JB, Monnier P, Fontolliet C, Savary M. The natural history, prevalence and incidence of reflux esophagitis. Gullet 1993;3 Suppl:3–10.
   Google Scholar
• Chang CS GH, Poon SK, Lien HC, Chen GH. The incidence of reflux esophagitis among the Chinese. Am J Gastroenterol 1997; 92:668–71.
   PubMedGoogle Scholar
• Armstrong D, Bennett JR, Blum AL, Dent J, De Dombal FT, Galmiche JP, et al. The endoscopic assessment of esophagitis: a progress report on observer agreement. Gastroenterology 1996; 111:85–92.
   PubMed Web of Science ®Google Scholar
• Lundell LR, Dent J, Bennett J, Blum AL, Armstrong D, Galmiche JP, et al. Endoscopic assessment of oesophagitis: clinical and functional correlates and further validation of the Los Angeles classification. Gut 1999;45:172–180.
   PubMed Web of Science ®Google Scholar
• Murphy DW, Castell DO. Chocolate and heartburn: evidence of increased esophageal acid exposure after chocolate ingestion. Am J Gastroenterol 1988;93:633–6.
   Google Scholar
• Pehl C, Wendl B, Pfeiffer A, Schmidt T, Kaess H. Low-proof alcoholic beverages and gastroesophageal reflux. Dig Dis Sci 1993;38:93–6.
   Google Scholar
• Sigmund CJ, McNally EF. The action of carminative on the lower esophageal sphincter. Gastroenterology 1969;56:13–8.
   PubMed Web of Science ®Google Scholar
• Wendl B, Pfeiffer A, Pehl C, Schmidt T, Kaess H. Effect of decaffeination of coffee or tea on gastro-esophageal reflux. Aliment Pharmacol Ther 1994;8:283–7.
   PubMed Web of Science ®Google Scholar
• Tsai MH, Lien HC, Chang CS, Chen GH. The trends of erosive esophagitis prevalence among people in Taiwan—comparison between 1995 and 2002. Gastroenterol J Taiwan 2003;20:38.
   Google Scholar
• Dent J, Holloway RH, Toouli J, Dodds WJ. Mechanisms of lower esophageal sphincter incompetence in patients with symptomatic gastro-esophageal reflux. Gut 1988;29:1020–8.
   PubMed Web of Science ®Google Scholar
• Nebel OT, Castell DO. Lower esophageal sphincter pressure changes after food ingestion. Gastroenterology 1972;63:778–83.
   PubMed Web of Science ®Google Scholar
• Ledeboer M, Masclee AA, Batstra MR, Jansen JB, Lamers CB. Effect of cholecystokinin on lower esophageal sphincter pressure and transient lower esophageal sphincter relaxation in humans. Gut 1995;36:39–44.
   Google Scholar
• Yeh C, Hsu CT, Ho AS, Sampliner RE, Fass R. Erosiveesophagitis and Barrett’s esophagus in Taiwan: a higher frequency than expected. Dig Dis Sci 1997;42:702–6.
   Google Scholar
• Blum aL, Adami B, Bouzo MH, Brandstatter G, Fumagalli I, Galmiche JP, et al. Effect of cisapride on relapse of esophagitis: a multinational, placebo controlled trial in patients healed with an antisecretory drug. Dig Dis Sci 1993;38: 551–60.
   Google Scholar
• Poynard T. Relapse rate of patients after healing of esophagitis— a prospective study of alginate as self-care treatment for 6 months. Aliment Pharmacol Ther 1993;7:385–92.
   PubMed Web of Science ®Google Scholar
• Koelz HR, Brichler R, Bretholz A, Bron B, Capitaine Y, Delmore G, et al. Healing and relapse of reflux esophagitis during treatment with ranitidine. Gastroenterology 1986;91:1198–205.
   PubMed Web of Science ®Google Scholar
• Hetzel DJ, Dent J, Reed WD, Narielvala FM, Mackinnon M, McCarthy JH, et al. Healing and relapse of severe peptic esophagitis after treatment with omeprazole. Gastroenterology 1988;95:903–12.
   PubMed Web of Science ®Google Scholar
• Schindlbeck NE, Klauser AG, Berghammer G, Londong W, MullerLissner SA. Three-year follow-up of patients with gastroesophageal reflux disease. Gut 1992;33:1016–9.
   Google Scholar
• Pace F, Santalucia F, Bianchi Porro G. Natural history of gastroesophageal reflux disease without esophagitis. Gut 1991; 32: 845–8.
   Google Scholar
• McDougall NI, Johnston BT, Kee F, Collins JSA, McFarland RJ, Love AHG. Natural history of reflux esophagitis: a 10-year follow up of its effect on patient symptomatology and quality of life. Gut 1996;38:461–6.
   Google Scholar
• Dent J, Yeomans ND, Mackinnon M, Reed W, Narielvala FM, Hetzel DJ, et al. Omeprazole vs ranitidine for prevention of relapse in reflux esophagitis. A controlled double blind trial of their efficacy and safety. Gut 1994;35:590–8.
   Google Scholar
• Howden CW, Castell DO, Cohen S, Freston JW, Orlando RC, Robinson M, et al. The rationale for continuous maintenance treatment of reflux esophagitis. Arch Intern Med 1995;155:1465–71.
   PubMedGoogle Scholar
• Marsh TD. Nonprescription H2-receptor antagonists. J Am Pharm Assoc 1997;NS37:552–6.
   Google Scholar
• Peghini PL, Katz PO, Bracy NA, Castell DO. Nocturnal recovery of gastric acid secretion with twice-daily dosing of proton pump inhibitors. Am J Gastroenterol 1998;93:763–7.
   PubMed Web of Science ®Google Scholar
• Harris RA, Kuppermann M, Richter JE. Prevention of recurrences of erosive reflux esophagitis: a cost-effectiveness analysis of maintenance proton pump inhibitor. Am J Med 1997;102:78–88.
   Google Scholar
• Robinson MG, Lanza F, Avner D. Effective maintenance treatment of reflux esophagitis with low-dose lansoprazole: a randomized, double-blind, placebo-controlled trial. Ann Intern Med 1996;24:859–67.
   Google Scholar
• Lin BR, Liao CC, Chen CF, Liao WR, Wang TH. Rapid increase in the prevalence of gastroesophageal reflux disease in an eastern country with fast-westernizing lifestyle—Taiwan. Gastroenterology 2003;124 Suppl 1:A167.
   Google Scholar
• Chang SS, Lu CL, Chao JY, Chao Y, Yen SH, Chang FY, et al. Unchanging trend of adenocarcinoma of the esophagus and gastric cardia in Taiwan: A 15-year experience in a single center. Dig Dis Sci 2002;47:735–40.
   PubMedGoogle Scholar